An overview of adjuvant therapy for colorectal cancer
- 31 August 1995
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (7-8), 1255-1263
- https://doi.org/10.1016/0959-8049(95)00258-k
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Mechanism of Synergy of Levamisole and Fluorouracil: Induction of Human Leukocyte Antigen Class I in a Colorectal Cancer Cell LineJNCI Journal of the National Cancer Institute, 1995
- The Long-Term Effect of Adjuvant Postoperative Chemoradiotherapy for Rectal Carcinoma on Bowel FunctionAnnals of Surgery, 1994
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Adjuvant therapy of colorectal cancer. Why we still don't knowPublished by American Medical Association (AMA) ,1988
- Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011JNCI Journal of the National Cancer Institute, 1988
- Survival after Postoperative Combination Treatment of Rectal CancerNew England Journal of Medicine, 1986
- Prolongation of the Disease-Free Interval in Surgically Treated Rectal CarcinomaNew England Journal of Medicine, 1985
- A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancerBritish Journal of Surgery, 1985
- Adjuvant Therapy of Colon Cancer — Results of a Prospectively Randomized TrialNew England Journal of Medicine, 1984